RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Akari Therapeutics Plc stock price on Thursday which ended trading at $1.87
(Updated on Mar 28, 2024)

Sell candidate since Mar 14, 2024 Loss -8.58% PDF

The Akari Therapeutics Plc stock price gained 0.269% on the last trading day (Thursday, 28th Mar 2024), rising from $1.86 to $1.87. During the last trading day the stock fluctuated 10.27% from a day low at $1.72 to a day high of $1.90. The price has fallen in 7 of the last 10 days and is down by -8.58% for this period. Volume fell on the last day by -21 thousand shares and in total, 14 thousand shares were bought and sold for approximately $25.39 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -35.34% during the next 3 months and, with a 90% probability hold a price between $1.12 and $1.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKTX Signals & Forecast

There are mixed signals in the stock today. The Akari Therapeutics Plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.17. On a fall, the stock will find some support from the short-term average at $1.86. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, March 22, 2024, and so far it has risen 3.04%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Akari Therapeutics Plc stock

Akari Therapeutics Plc finds support from accumulated volume at $1.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.177 between high and low, or 10.27%. For the last week the stock has had daily average volatility of 7.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKTX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Akari Therapeutics Plc to open at $1.83, and during the day (based on 14 day Average True Range), to move between $1.72 and $2.01, which gives a possible trading interval of +/-$0.149 (+/-8.00%) up or down from last closing price. If Akari Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 16.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.86 (0.27%) than the resistance at $2.14 (14.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akari Therapeutics Plc stock A Buy?

Akari Therapeutics Plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.963 Sell Candidate Unchanged

Predicted Opening Price for Akari Therapeutics Plc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$1.83 ( 1.92%) $1.87

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.01 7.57 %
R2 1.94 3.95 %
R1 1.90 1.71 %
Current price: 1.87
Support S1 1.76 -5.54 %
S2 1.72 -7.78 %
S3 1.65 -11.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.25 20.64 %
R2 2.22 19.03 %
R1 2.14 14.75 %
Current price 1.87
Support S1 1.86 -0.268%
S2 1.83 -1.88%
S3 1.81 -2.95%

FAQ

What is the symbol for Akari Therapeutics Plc Stock and on which exchange is it traded?
The symbol for Akari Therapeutics Plc is AKTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akari Therapeutics Plc Stock?
Akari Therapeutics Plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Akari Therapeutics Plc Stock?
Akari Therapeutics Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akari Therapeutics Plc Stock.

What's the current price of Akari Therapeutics Plc Stock?
As of the end of day on the 2024-03-28, the price of an Akari Therapeutics Plc (AKTX) share was $1.87.

What is the 52-week high and low for Akari Therapeutics Plc Stock?
The 52-week high for Akari Therapeutics Plc Stock is $5.50 and the 52-week low is $1.66.

What is the market capitalization of Akari Therapeutics Plc Stock?
As of the 2024-03-28, the market capitalization of Akari Therapeutics Plc is 9.439M.

When is the next earnings date for Akari Therapeutics Plc?
The upcoming earnings date for Akari Therapeutics Plc is May 06, 2024.
Click to get the best stock tips daily for free!

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT